The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication

• Published in: Journal of virology Vol. 92; no. 6
• Main Authors: Edwards, Terri G, Bloom, David C, Fisher, Chris
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 15.03.2018
• Subjects: Ataxia Telangiectasia Mutated Proteins - genetics; Ataxia Telangiectasia Mutated Proteins - metabolism; Cell Line; Checkpoint Kinase 1 - genetics; Checkpoint Kinase 1 - metabolism; DNA-Activated Protein Kinase - genetics; DNA-Activated Protein Kinase - metabolism; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Herpes Simplex - genetics; Herpes Simplex - metabolism; Herpes Simplex - pathology; Herpesvirus 1, Human - physiology; Humans; Immediate-Early Proteins - genetics; Immediate-Early Proteins - metabolism; Nuclear Proteins - genetics; Nuclear Proteins - metabolism; Signal Transduction; Ubiquitin-Protein Ligases - genetics; Ubiquitin-Protein Ligases - metabolism; Viral Proteins - genetics; Viral Proteins - metabolism; Virus Replication - physiology; Virus-Cell Interactions; herpes simplex virus; viral replication; Chk1; DNA damage response; ATM and Rad3-related (ATR) kinase; ATR
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/JVI.01884-17

The ATM and Rad3-related (ATR) protein kinase and its downstream effector Chk1 are key sensors and organizers of the DNA damage response (DDR) to a variety of insults. Previous studies of herpes simplex virus 1 (HSV-1) showed no evidence for activation of the ATR pathway. Here we demonstrate that both Chk1 and ATR were phosphorylated by 3 h postinfection (h.p.i.). Activation of ATR and Chk1 was observed using 4 different HSV-1 strains in multiple cell types, while a specific ATR inhibitor blocked activation. Mechanistic studies point to early viral gene expression as a key trigger for ATR activation. Both pATR and pChk1 localized to the nucleus within viral replication centers, or associated with their periphery, by 3 h.p.i. Significant levels of pATR and pChk1 were also detected in the cytoplasm, where they colocalized with ICP4 and ICP0. Proximity ligation assays confirmed that pATR and pChk1 were closely and specifically associated with ICP4 and ICP0 in both the nucleus and cytoplasm by 3 h.p.i., but not with ICP8 or ICP27, presumably in a multiprotein complex. Chemically distinct ATR and Chk1 inhibitors blocked HSV-1 replication and infectious virion production, while inhibitors of ATM, Chk2, and DNA-dependent protein kinase (DNA-PK) did not. Together our data show that HSV-1 activates the ATR pathway at early stages of infection and that ATR and Chk1 kinase activities play important roles in HSV-1 replication fitness. These findings indicate that the ATR pathway may provide insight for therapeutic approaches. Viruses have evolved complex associations with cellular DNA damage response (DDR) pathways, which sense troublesome DNA structures formed during infection. The first evidence for activation of the ATR pathway by HSV-1 is presented. ATR is activated, and its downstream target Chk1 is robustly phosphorylated, during early stages of infection. Both activated proteins are found in the nucleus associated with viral replication compartments and in the cytoplasm associated with viral proteins. We also demonstrate that both ATR and Chk1 kinase activities are important for viral replication. The findings suggest that HSV-1 activates ATR and Chk1 during early stages of infection and utilizes the enzymes to promote its own replication. The observation may be exploitable for antiviral approaches.